Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata

NCT06157905 is registered in ClinicalTrials.gov with Services Institute of Medical Sciences, Pakistan as lead sponsor.

NCT NCT06157905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06157905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata
Lead sponsor
Services Institute of Medical Sciences, Pakistan
Phase
Phase 1
Overall status
Completed
Start date
August 6, 2022
Completion date
August 4, 2023
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extensive alopecia areata